Katrien Swerts

Show Sort by

Add to list
- Journal Article
- A1
- open access
N-Cadherin in neuroblastoma disease : expression and clinical significance

Tim Lammens (UGent) , Katrien Swerts (UGent) , Lara Derycke (UGent) , Annemie De Craemer (UGent) , Sara De Brouwer (UGent) , Katleen De Preter (UGent) , Nadine Van Roy (UGent) , Jo Vandesompele (UGent) , Franki Speleman (UGent) , Jan Philippé (UGent) , et al.

(2012) PLOS ONE. 7(2).
Add to list
- Journal Article
- A1
Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization

Mado Vandewoestyne, Candy Kumps (UGent) , Katrien Swerts (UGent) , Björn Menten (UGent) , Tim Lammens (UGent) , Jan Philippé (UGent) , Katleen De Preter (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Franki Speleman (UGent) , et al.

(2012) INTERNATIONAL JOURNAL OF CANCER. 130(5). p.1098-1108
Add to list
- Journal Article
- A1
Hop bitter acids efficiently block inflammation independent of GRα, PPARα, or PPARγ

Marjan Van Cleemput (UGent) , Arne Heyerick (UGent) , Claude Libert (UGent) , Katrien Swerts (UGent) , Jan Philippé (UGent) , Denis De Keukeleire (UGent) , Guy Haegeman (UGent) and Karolien De Bosscher (UGent)

(2009) MOLECULAR NUTRITION & FOOD RESEARCH. 53(9). p.1143-1155
Add to list
- Journal Article
- A1
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , Arlene Naranjo, Liesbeth Vercruysse (UGent) , Nadine Van Roy (UGent) , Jan Hellemans, Katrien Swerts (UGent) , Sophie Bravo, Paolo Scaruffi, Gian Paolo Tonini, et al.

(2009) LANCET ONCOLOGY. 10(7). p.663-671
Add to list
- Journal Article
- A1
- open access
Array comparative genomic hybridization and flow cytometry analysis of spontaneous abortions and mors in utero samples

Björn Menten (UGent) , Katrien Swerts (UGent) , BARBARA DELLE CHIAIE (UGent) , Sandra Janssens (UGent) , Karen Buysse (UGent) , Jan Philippé (UGent) and Franki Speleman (UGent)

(2009) BMC MEDICAL GENETICS. 10.
Add to list
- Conference Paper
- C3
Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.

Barbara De Moerloose (UGent) , Katrien Swerts (UGent) , M Bakkus, A Uyttebroeck, N Boeckx, P Vandenberghe, Bruno Verhasselt (UGent) , A Van Damme, C Demanet, Yves Benoit, et al.

(2008) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. p.198-198
Add to list
- Journal Article
- A1
Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials

VF VIPREY, MA LASTOWSKA, MV CORRIAS, Katrien Swerts (UGent) , MS JACKSON and SA BURCHILL

(2008) JOURNAL OF PATHOLOGY. 216(2). p.245-252
Add to list
- Conference Paper
- C3
Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.

Barbara De Moerloose (UGent) , Katrien Swerts (UGent) , M BAKKUS, A UYTTEBROECK, N BOECKX, P VANDENBERGHE, Bruno Verhasselt (UGent) , A VAN DAMME, C DEMANET, Jan Philippé (UGent) , et al.

(2008) BRITISH JOURNAL OF HAEMATOLOGY. 141. p.88-88
Add to list
- Conference Paper
- C3
Minimal residual disease detection at day 35 in childhood acute lymphoblastic leukemia: Which technique(s) to use?

Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , B DENYS, M BAKKUS, Bruno Verhasselt (UGent) , Yves Benoit and Jan Philippé (UGent)

(2008) CYTOMETRY PART B-CLINICAL CYTOMETRY. 74B(1). p.76-77
Add to list
- Conference Paper
- C3
Prognostic value of BCL2L13 expression in childhood B-cell acute lymphoblastic leukaemia

Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , Catharina Dhooge (UGent) , Yves Benoit and Jan Philippé (UGent)

(2007) ACTA CLINICA BELGICA. 62(4). p.261-261
Add to list
- Journal Article
- A1
DRAQ5: improved flow cytometric residual disease detection DNA content analysis and minimal in childhood malignancies

Katrien Swerts (UGent) , Nadine Van Roy (UGent) , Yves Benoit, Genevieve Laureys (UGent) and Jan Philippé (UGent)

(2007) CLINICA CHIMICA ACTA. 379(1-2). p.154-157
Add to list
- Journal Article
- A1
Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET

VF VIPREY, MV CORRIAS, B KAGEDAL, S OLTRA, Katrien Swerts (UGent) , A VICHA, R LADENSTEIN and SA BURCHILL

(2007) EUROPEAN JOURNAL OF CANCER. 43(2). p.341-350
Add to list
- Journal Article
- A2
Opsporing en klinisch belang van minimale residuele ziekte bij neuroblastoompatiënten

Katrien Swerts (UGent) , Yves Benoit, Genevieve Laureys (UGent) and Jan Philippé (UGent)

(2006) TIJDSCHRIFT VOOR GENEESKUNDE. 62. p.1312-1320
Add to list
- Journal Article
- A1
Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells

Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , Catharina Dhooge (UGent) , Jo Vandesompele (UGent) , C HOYOUX, K BEISKE, Yves Benoit, Genevieve Laureys (UGent) and Jan Philippé (UGent)

(2006) CLINICAL CHEMISTRY. 52(3). p.438-445
Add to list
- Journal Article
- A1
Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia

Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , Catharina Dhooge (UGent) , Genevieve Laureys (UGent) , Yves Benoit and Jan Philippé (UGent)

(2006) EUROPEAN JOURNAL OF CANCER. 42(3). p.295-309
Add to list
- PhD Thesis
- open access
Multidrug resistance and minimal residual disease in childhood malignancies

Katrien Swerts (UGent)

(2005)
Add to list
- Journal Article
- A4
Detectie van minimale residuele ziekte bij kinderen met neuroblastoom

Barbara De Moerloose (UGent) and Katrien Swerts (UGent)

(2005) VERHANDELINGEN VAN DE KONINKLIJKE ACADEMIE VOOR GENEESKUNDE VAN BELGIË. 67(1). p.34-44
Add to list
- Journal Article
- A1
Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow

Katrien Swerts (UGent) , PF AMBROS, C BROUZES, JMF NAVARRO, N GROSS, D RAMPLING, R SCHUMACHER-KUCKELKORN, AR SEMENTA, R LADENSTEIN and K BEISKE

(2005) JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 53(12). p.1433-1440
Add to list
- Journal Article
- A1
Detecting minimal residual disease in neuroblastoma patients - the present state of the art

K BEISKE, PF AMBROS, SA BURCHILL, IY CHEUNG and Katrien Swerts (UGent)

(2005) CANCER LETTERS. 228(1-2). p.229-240
Add to list
- Conference Paper
- C1
Four-color flow cytometric detection of residual neuroblastoma cells

Jan Philippé (UGent) , Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , Catharina Dhooge (UGent) , Yves Benoit and Genevieve Laureys (UGent)

(2004) Cytometry Part A. 59A(1). p.66-66
Add to list
- Journal Article
- A1
Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia

Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , Catharina Dhooge (UGent) , Lucien Noens (UGent) , Genevieve Laureys (UGent) , Yves Benoit and Jan Philippé (UGent)

(2004) LEUKEMIA & LYMPHOMA. 45(11). p.2221-2228
Add to list
- Conference Paper
- C1
The quantification of MDR1 transcripts by real-time RT-PCR does not predict drug resistance in childhood acute lymphoblastic leukemia

Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , B LEUS, Catharina Dhooge (UGent) , Genevieve Laureys (UGent) , Bruno Verhasselt (UGent) , Yves Benoit and Jan Philippé (UGent)

(2003) Leukemia. 17(3). p.677-677
Add to list
- Journal Article
- A2
Actuele inzichten en prognostische karakteristieken van het neuroblastoom

Barbara De Moerloose (UGent) , Katrien Swerts (UGent) and Genevieve Laureys (UGent)

(2003) TIJDSCHRIFT VOOR GENEESKUNDE. 59. p.587-595
Add to list
- Journal Article
- A1
The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia

Barbara De Moerloose (UGent) , Katrien Swerts (UGent) , Yves Benoit, Genevieve Laureys (UGent) , Tom Loeys (UGent) , Jan Philippé (UGent) and Catharina Dhooge (UGent)

(2003) PEDIATRIC HEMATOLOGY AND ONCOLOGY. 20(5). p.381-391
Add to list
- Conference Paper
- C3
Imaging with Technetium-99m sestamibi does not predict drug resistance or outcome in childhood neuroblastoma

C VAN DE WIELE, B DE MOERLOOSE, Genevieve Laureys (UGent) , Catharina Dhooge (UGent) , Katrien Swerts (UGent) , Yves Benoit, J PHILIPP and Rudi Dierckx (UGent)

(2001) EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 28(8). p.1177-1177
Add to list
- Conference Paper
- C1
Combined evaluation of P-glycoprotein expression and activity contributes to the identification of children at risk for leukaemic relapse

Barbara De Moerloose (UGent) , Katrien Swerts (UGent) , Catharina Dhooge (UGent) , S STEYAERT, Yves Benoit, Genevieve Laureys (UGent) and Jan Philippé (UGent)

(2001) Leukemia. 15(3). p.501-501

Academic Bibliography

Katrien Swerts

N-Cadherin in neuroblastoma disease : expression and clinical significance

Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization

Hop bitter acids efficiently block inflammation independent of GRα, PPARα, or PPARγ

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Array comparative genomic hybridization and flow cytometry analysis of spontaneous abortions and mors in utero samples

Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.

Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials

Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.

Minimal residual disease detection at day 35 in childhood acute lymphoblastic leukemia: Which technique(s) to use?

Prognostic value of BCL2L13 expression in childhood B-cell acute lymphoblastic leukaemia

DRAQ5: improved flow cytometric residual disease detection DNA content analysis and minimal in childhood malignancies

Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET

Opsporing en klinisch belang van minimale residuele ziekte bij neuroblastoompatiënten

Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells

Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia

Multidrug resistance and minimal residual disease in childhood malignancies

Detectie van minimale residuele ziekte bij kinderen met neuroblastoom

Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow

Detecting minimal residual disease in neuroblastoma patients - the present state of the art

Four-color flow cytometric detection of residual neuroblastoma cells

Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia

The quantification of MDR1 transcripts by real-time RT-PCR does not predict drug resistance in childhood acute lymphoblastic leukemia

Actuele inzichten en prognostische karakteristieken van het neuroblastoom

The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia

Imaging with Technetium-99m sestamibi does not predict drug resistance or outcome in childhood neuroblastoma

Combined evaluation of P-glycoprotein expression and activity contributes to the identification of children at risk for leukaemic relapse

Contents

Support

Contact